BioHarvest Sciences Inc. (BHST)
(Delayed Data from NSDQ)
$8.71 USD
-0.30 (-3.28%)
Updated Sep 18, 2025 03:25 PM ET
After-Market: $8.80 +0.10 (1.09%) 5:20 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BHST 8.71 -0.30(-3.28%)
Will BHST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BHST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BHST
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates
The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates
BHST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sarepta Therapeutics (SRPT) Tops Q2 Earnings and Revenue Estimates
BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains?
What Makes BioHarvest Sciences Inc. (BHST) a Good Fit for 'Trend Investing'
Other News for BHST
BHST forms Calm After Storm on September 17
BHST forms MACD Bullish Centerline Cross on September 16
Is BHST poised for gains? MACD Bullish Signal Line Cross shows up after advancing 3.08%
BHST Crossed Above 20 Day Moving Average on September 12
The technical outlook for BHST is unchanged after it falls 0.93% on September 11